# AstraZeneca to sell its West Chester site to National Resilience

- Link: https://www.directorstalkinterviews.com/astrazeneca-to-sell-its-west-chester-site-to-national-resilience/4121092441
- Published: 2022-11-30T07:30:25+00:00
- Author: Amilia Stone

**[AstraZeneca plc](https://www.directorstalkinterviews.com/ftse-company/astrazeneca/azn.l)**(
[LON:AZN](https://www.directorstalkinterviews.com/ftse-company/astrazeneca/azn.l))
has announced the sale of its West Chester site in Ohio, US, to National Resilience,
Inc., a technology-focused manufacturing company dedicated to broadening access 
to complex medicines.

> **Andrew Wirths, Senior Vice President, Americas Supply Region, AstraZeneca, said**:“
> As part of our long-term strategy to ensure our global supply network remains 
> fit for the future, we are continuously optimising our manufacturing footprint
> to meet the evolving needs of our pipeline and portfolio. The transfer of our 
> West Chester site to Resilience will enable the continued supply of AstraZeneca
> medicines to patients, as well as the continued employment for more than 500 people
> working at the West Chester site. I’m encouraged by Resilience’s plans to transform
> the site into their drug product centre of excellence.”

> “The West Chester site will play an important role in the delivery of our mission
> to broaden access to complex medicines, protect biopharmaceutical supply chains,
> and strengthen domestic preparedness,” **said Rahul Singhvi, Sc.D, Chief Executive
> Officer of Resilience. **“I’m confident that West Chester’s premier capabilities,
> including the talented employees who are joining Resilience, will help us expand
> our business in new directions.”

AstraZeneca expects to complete the sale in the first quarter of 2023, with a phased
transition of services.

Share on: